153 related articles for article (PubMed ID: 2970825)
1. [Neocarzinostatin therapy of advanced renal cell carcinoma].
Tari K; Satake I; Kojima S; Tsujii T; Yonese J
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic effects of perioperatively administered neocarzinostatin in renal cell carcinoma.
Satake I; Tari K; Ohwada F; Saitoh T; Negishi T
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):809-16. PubMed ID: 2528598
[TBL] [Abstract][Full Text] [Related]
3. [Use of arterial infusion of neocarzinostatin with or without combination chemotherapy as a treatment of carcinoma of the prostate].
Yuasa M; Numata A; Tanaka T; Kawanishi Y; Yamamoto A; Imagawa A
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2325-30. PubMed ID: 2425748
[TBL] [Abstract][Full Text] [Related]
4. [A case of complete regression of metastatic renal cell carcinoma following corticosteroid treatment].
Tanaka M; Fukuda H; Higashi Y
Hinyokika Kiyo; 2003 Apr; 49(4):225-8. PubMed ID: 12784718
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
[TBL] [Abstract][Full Text] [Related]
6. [Missile therapy of colorectal and pancreatic cancers--clinical trial of monoclonal antibody, A7-NCS, in 73 patients with colorectal and pancreatic cancers].
Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M; Otsuji E
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1111-9. PubMed ID: 2140933
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000.
Gez E; Rubinov R; Gaitini D; Meretyk S; Best LA; Native O; Stein A; Erlich N; Beny A; Zidan J; Haim N; Kuten A
Cancer; 2002 Oct; 95(8):1644-9. PubMed ID: 12365011
[TBL] [Abstract][Full Text] [Related]
8. Surgery of metastatic renal cell carcinoma and use of renal infarction.
Swanson DA; Wallace S
Semin Surg Oncol; 1988; 4(2):124-8. PubMed ID: 3293153
[TBL] [Abstract][Full Text] [Related]
9. Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose.
Hamada I; Kato M; Okada K
Anticancer Res; 2002; 22(4):2429-36. PubMed ID: 12174939
[TBL] [Abstract][Full Text] [Related]
10. Neocarzinostatin-induced complete regression of metastatic renal cell carcinoma.
Satake I; Tari K; Yamamoto M; Nishimura H
J Urol; 1985 Jan; 133(1):87-9. PubMed ID: 3155476
[TBL] [Abstract][Full Text] [Related]
11. [Primary metastasized hypernephroma: therapy and follow-up].
Hienert VG; Latal D; Kühböck J; Rummelhardt S
Z Urol Nephrol; 1987 Dec; 80(12):669-74. PubMed ID: 3442132
[TBL] [Abstract][Full Text] [Related]
12. [Reductive effect on ascites, of neocarzinostatin in patients with ovarian cancer].
Takahashi K; Watanabe M; Kikuchi J; Kishi H; Saito K; Mouri H; Ikeno N; Endo H; Shima I; Morizuka T
Gan To Kagaku Ryoho; 1988 May; 15(5):1777-81. PubMed ID: 2967052
[TBL] [Abstract][Full Text] [Related]
13. A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma.
Huland E; Heinzer H; Huland H
Folia Biol (Praha); 2000; 46(6):241-50. PubMed ID: 11140857
[TBL] [Abstract][Full Text] [Related]
14. Conservative surgery of renal cell carcinoma.
Ziv Y; Gillon G; Nissenkorn I; Servadio C
Isr J Med Sci; 1986 Dec; 22(12):885-7. PubMed ID: 3570732
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of arterial infusion chemotherapy with neocarzinostatin on inoperable hepatoma].
Sasaki Y; Fujita S; Yoshioka H; Takimoto C; Mitsutani N; Koizumi T
Gan To Kagaku Ryoho; 1982 May; 9(5):898-905. PubMed ID: 6307185
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of neocarzinostatin in digestive system cancer. 1. Administration of neocarzinostatin in advanced and recurrent carcinoma of the stomach].
Kikuchi K; Kusama S; Furue H; Muto T; Toriyama K; Wakiya M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1866-71. PubMed ID: 6224465
[TBL] [Abstract][Full Text] [Related]
18. "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen.
Giacosa R; Santi R; Vaglio A; Pavone L; Ferrozzi F; Passalacqua R; Buzio C
Acta Biomed; 2004 Aug; 75(2):126-30. PubMed ID: 15481703
[TBL] [Abstract][Full Text] [Related]
19. Salvage paclitaxel chemotherapy for metastatic collecting duct carcinoma of the kidney.
Bagrodia A; Gold R; Handorf C; Liman A; Derweesh IH
Can J Urol; 2008 Dec; 15(6):4425-7. PubMed ID: 19046497
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
